Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Therma Bright Inc V.THRM

Alternate Symbol(s):  TBRIF

Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and... see more

TSXV:THRM - Post Discussion

Therma Bright Inc > ✅The Global Rapid Diagnostic Tests (RDT)
View:
Post by Siberia on Jun 06, 2022 2:59am

✅The Global Rapid Diagnostic Tests (RDT)

NEW YORK, UNITED STATES, June 2, 2022 /EINPresswire.com/ . The Global Rapid Diagnostic Tests (RDT) Market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses that the market is growing with a CAGR of 9.3% in the forecast period of 2022 to 2029 and is expected to reach USD 74,674.92 million by 2029 from USD 38,363.51 million in 2021. More info at: https://www.einnews.com/pr_news/575042581/rapid-diagnostic-tests-rdt-market-share-size-demand-growth-key-players-trends-and-regional-forecast-to-2029
Comment by Siberia on Jun 08, 2022 12:02am
NEW YORK, UNITED STATES, June 2, 2022 /EINPresswire.com/ . The Global Rapid Diagnostic Tests (RDT) Market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses that the market is growing with a CAGR of 9.3% in the forecast period of 2022 to 2029 and is expected to reach USD 74,674.92 million by 2029 from USD 38,363.51 million in 2021. More ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities